• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[我们使用三相避孕药物Trisiston进行避孕的经验]

[Our experience in using the triphasic contraceptive trisiston for contraception].

作者信息

Vasilev D, Katsarova M, Dikov I

出版信息

Akush Ginekol (Sofiia). 1989;28(3):63-6.

PMID:2802085
Abstract

The authors carried out studies on 80 women, using Trisistone, a preparation of Germed, Jenapharm, DDR, in the course of 250 cycles, taking into consideration the advantages of triphasic contraceptive preparations as well as the fact that till this moment there were not applied in our country. A good contraceptive efficiency was established. No case with conception was recorded. The side effects were mild and and their frequency varies between 2.4 and 9.7% Irregular bleedings were the only disadvantage of Trisistone, which caused refusal for its usage. It is proposed that Trisistone should be used as an initial contraceptive preparation like the preparations with "mini" doses. In cases with good tolerance women should continue to use it, but they should take another contraceptive preparation, when bleeding occurs.

摘要

作者对80名女性进行了研究,在250个周期中使用了民主德国耶拿制药厂生产的三烯高诺酮制剂“Trisistone”,同时考虑到三相避孕制剂的优点以及当时我国尚未应用这一情况。研究确立了良好的避孕效果。未记录到怀孕案例。副作用轻微,其发生率在2.4%至9.7%之间。不规则出血是三烯高诺酮唯一的缺点,这导致一些女性拒绝使用它。建议将三烯高诺酮像“小剂量”制剂一样用作初始避孕制剂。对于耐受性良好的女性,应继续使用它,但在出现出血情况时应更换为其他避孕制剂。

相似文献

1
[Our experience in using the triphasic contraceptive trisiston for contraception].[我们使用三相避孕药物Trisiston进行避孕的经验]
Akush Ginekol (Sofiia). 1989;28(3):63-6.
2
[The use of the triphasic contraceptive preparation trisiston for therapeutic purposes].[三相避孕制剂Trisiston用于治疗目的]
Akush Ginekol (Sofiia). 1990;29(1):79-83.
3
[A clinical trial and use of triziston-R as a contraceptive agent].
Akush Ginekol (Sofiia). 1989;28(5):67-9.
4
[Practical observations of the use of the contraceptive preparation Anteovin].[避孕药安特奥芬使用的实际观察]
Akush Ginekol (Sofiia). 1990;29(6):88-90.
5
Clinical experience with a triphasic oral contraceptive containing ethinyloestradiol and levonorgestrel in Nigerian women.
West Afr J Med. 1989 Apr-Jun;8(2):116-21.
6
Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
Int J Fertil. 1988 Nov-Dec;33(6):406-10.
7
Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.孕二烯酮与炔雌醇三相复方口服避孕药:一项多中心临床研究结果
Int J Fertil. 1987;32 Suppl:45-8.
8
Oral contraception, 1986. Focus on Triphasil.口服避孕药,1986年。聚焦于三相片。
J Reprod Med. 1986 Jun;31(6 Suppl):559-64.
9
[The clinico-pharmacological characteristics of anteovin].[安特奥文的临床药理学特征]
Farmakol Toksikol. 1991 Jan-Feb;54(1):30-1.
10
Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.两种双相和一种三相炔诺孕酮/炔雌醇方案的临床评估。
Int J Fertil. 1978;23(3):193-9.